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Long-term potentiation (LTP) and long-term depression (LTD) are the major forms of functional synaptic plasticity observed at CA1 synapses
of the hippocampus. The balance between LTP and LTD or “metaplasticity” is controlled by G-protein coupled receptors (GPCRs) whose signal
pathways target the N-methyl-D-asparate (NMDA) subtype of excitatory glutamate receptor. We discuss the protein kinase signal cascades
stimulated by Gαq and Gαs coupled GPCRs and describe how control of NMDAR activity shifts the threshold for the induction of LTP.
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The primary function of ionotropic glutamate receptors is to
respond to presynaptically released transmitter by generating
depolarizing and excitatory postsynaptic potentials (epsps). As
a result, rapid and high-resolution excitatory signals are passed
from the presynaptic to the postsynaptic neuron. Spatial and⁎ Corresponding author. Tel.: +1 416 978 2674; fax: +1 416 978 4940.
E-mail address: j.macdonald@utoronto.ca (J.F. MacDonald).
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doi:10.1016/j.bbamem.2006.12.006temporal summation of these epsps at the level of a single
postsynaptic neuron provides convergence and integration of a
diversity of excitatory inputs from many presynaptic neurons.
The majority of epsps in the mammalian central nervous
system are mediated by the α-amino-3-hydroxy-5-isoxazole-
propionic acid (AMPA) and N-methyl-D-aspartate (NMDA)
subtype of ionotropic (ion channel) glutamate receptors [1].
Almost all excitatory glutamatergic synapses possess both of
these receptors, but the unitary epsp is almost entirely generated
by current flow through AMPARs because of a voltage-
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extracellular Mg2+. It is not until there is sufficient depolariza-
tion of the postsynaptic membrane and relief of the Mg2+ block
via temporal and spatial summation of epsps that NMDARs
contribute substantially to the generation of epsps [2]. At some
specialized synapses, such as the calyx of Held synapse,
AMPARs predominate and permit the postsynaptic cell to
respond to presynaptic action potential frequencies of greater
than 100 Hz [3].
Both AMPARs and NMDARs are tetrameric, non-selective
cation channels (permeable to Na+ and K+) composed of GluR
subunits (GluR1, 2, 3, 4) for AMPARs, and NR subunits
(NR11-11splice variants, NR2A, B, C, D and NR3A, B) in the case
of NMDARs [4,5]. NMDARs provide a significant influx
pathway for Ca2+ and the activity of these receptors is, as a
consequence, coupled to a variety of Ca2+-dependent intracel-
lular signaling pathways. In contrast, the presence of the GluR2
subunit in most AMPARs dramatically reduces their perme-
ability to Ca2+ [6]. Therefore, AMPARs are particularly well
suited for generating unitary epsps and NMDARs serve as
coincidence detectors in that the influx of Ca2+ via these
channels is directly related to the degree of spatial and temporal
summation of excitatory inputs to the postsynaptic cell [2].
Beyond simple direct signaling between neurons, NMDARs are
important for the development of neurons and for the
establishment of synaptic contacts [7]. They also play important
roles in controlling the morphological and functional plasticity
of synapses and contribute to the cellular mechanisms of
learning and memory [8]. Paradoxically, overstimulation of
NMDARs can lead to pathological conditions that may
contribute to major degenerative diseases as well as to cell
death in stroke and epilepsy [9]. Therefore, the basal level of
NMDAR activity is pivotal to neuronal development, signaling
and to the maintenance of neuronal viability.
2. Functional synaptic plasticity
Over the last several decades, considerable effort has been
expended by researchers to determine the molecular and genetic
basis of synaptic plasticity as well as its relationship to simple
forms of learning and memory [10,11]. At many synapses in the
CNS, long-term alterations of excitatory synaptic strength,
induced by specific patterns of repetitive synaptic activity, serve
as widely studied models of functional synaptic plasticity. For
example, high-frequency tetanic stimulation typically elicits
long-term potentiation (LTP) of epsps whereas repetitive low-
frequency stimulation induces a long lasting depression (LTD)
of these responses. These forms of synaptic plasticity are widely
studied at excitatory synapses impinging upon CA1 pyramidal
neurons where they are thought to underlie various forms of
spatial learning and memory. The induction of LTP and LTD at
these synapses paradoxically requires the activation of synaptic
NMDARs [12,82]. Notably, NMDAR activation contributes to
plasticity not only at high stimulus frequencies (>50 Hz), where
relief of Mg2+ block is expected to be nearly complete, but also
at very low frequencies of synaptic stimulation (∼1 Hz). In
other words, NMDARs can still contribute small but detectableCa2+ signals in the dendritic spines of CA1 neurons even under
conditions when their contribution to the current underlying the
epsp is minimal. As a result of the different levels of NMDAR
activation, LTP- and LTD-inducing stimulation protocols will
consequently generate distinct Ca2+ signals. These differ in the
absolute concentrations of Ca2+ achieved, especially within
postsynaptic micro-domains, and in the kinetics of the resulting
signal. Consequently, these distinct Ca2+ signals will recruit
distinct signal transduction pathways that ultimately will
determine whether LTP or LTD, expressed through changes in
AMPAR function, is induced.
Although a large number of molecules and signal transduc-
tion pathways have been implicated in synaptic plasticity, not all
of these are likely to be both “sufficient and necessary” for
either the induction and/or maintenance of LTP and LTD
[13,14] . The signal components that have emerged as leading
candidates include the activation and autophosphorylation of
CamKII necessary for the establishment of LTP and the
activation of protein phosphatases, including protein phospha-
tases 1 (PP1) and calcineurin, necessary for the establishment of
LTD. These kinases and phosphatases alter the phosphorylation
of AMPARs resulting in changes in single-channel conductance
as well as changes AMPAR surface expression [15,16].
Ultimately however, the sustained maintenance of a resultant
plastic change must involve changes in gene expression. In the
case of LTP, this may occur, for example, through PKA-induced
stimulation of CREB [17,18] or through NMDAR-dependent
stimulation of MAPK signaling cascades [19,20].
3. Metaplasticity
The threshold for the induction of LTP and LTD can be
influenced by prior activity within the network which does not
itself alter the amplitude of the basal epsp or the efficacy of
synaptic transmission. This type of “plasticity of plasticity” has
been termed “metaplasticity” [21]. The potential mechanism(s)
of metaplasticity are numerous and include changes in the
effectiveness of GABA-mediated synaptic inhibition [22].
However, given the ability of NMDARs to function as a gate
for the induction of several forms of synaptic plasticity, changes
in NMDAR function are clearly the most direct way to alter the
thresholds of synaptic plasticity without detectably altering
basal epsps. An early example was reported by Coan et al. [23]
which showed that depriving hippocampal slices of extracellular
Mg2+ caused a subsequent inhibition of the induction of LTP
(increase in threshold). This was entirely unexpected because
the reduction in Mg2+ would lead to enhanced NMDAR
activation and would be predicted to cause a reduction in the
threshold for LTP. Indeed relatively weak pre-stimulation of
NMDARs by a variety of mechanism leads to alterations in the
relative balance between the induction of LTP and LTD [12,21].
One means by which pre-stimulation may alter NMDAR
function is by modifying tyrosine phosphorylation through the
activities of specific kinases and phosphatases [12]. Many of
these enzymes are in fact highly localized within NMDAR
micro-domains or even intimately associated with the receptors
themselves. For example, the Src family kinases, including Src
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by promoting tyrosine phosphorylation and dephosphorylation
respectively (see extensive reviews by Salter [24–26]).
Interestingly, Src is both “sufficient and necessary” for the
induction of LTP at CA1 synapses [27]. It is noteworthy that
basal AMPAR-mediated epsps are unaltered by applications of
Src-specific inhibitors even though they block the subsequent
induction of LTP [27]. These results illustrate that Src is not
actively up-regulating NMDAR activity under basal conditions.
The LTP-inducing period of high frequency stimulation (the
tetanic stimulation) leads to the entry of Na+ and Ca2+ and
activates Src [28,29] that in turn facilitates NMDAR channel
activity providing a biochemical mechanism of positive feed-
back on NMDARs. This means that synaptically located Src
family kinases are an ideal target to underlie mechanisms of
metaplasticity.
Consequently, prior activity need not necessarily cause
substantial NMDAR activation in order to induce metaplasti-
city. Such activity could alternatively cause the activation of
several GPCRs capable of regulating the function of NMDARs
and thus the ability to subsequently induce plasticity. Indeed, a
wide variety of G-protein coupled receptors (GPCRs), including
those for glutamate, acetylcholine and dopamine, converge via
their signal pathways to alter the gating and/or the trafficking of
NMDARs by regulating the activities of Src family kinases and
tyrosine phosphatases. GPCRs are also known to regulate
receptor tyrosine kinases (RTKs), such as epidermal growth
factor receptors (EGFRs) and platelet derived growth factor
receptors (PDGFRs) [30]. These RTKs can in turn alter
NMDAR expression and function [31].
There are a variety of ways that GPCR signaling could
converge to alter NMDAR activity at CA1 synapses and thereby
contribute to metaplasticity. For example, the GPCR or its
related G-protein components can:
(1) Bind directly to a subunit of the NMDAR and alter its
activity or trafficking [32].
(2) Activate a second messenger cascade linked to the
serine–threonine kinases (e.g. PKC, CAMK or PKA)
which leads to a direct increase or decrease in
phosphorylation of NMDAR subunits [7].
(3) Activate a signal cascade that increases or decreases the
phosphorylation of an accessory protein that brings the
NMDAR into or out of the appropriate proximity of a
given signaling enzyme [33].
(4) Activate signals that target a RTK which in turn regulates
the activity of NMDARs [31].
(5) Activate signals that target the proteins responsible for
regulating actin polymerization which in turn alters
NMDAR activity or possibly their trafficking [34].
In this review we will examine how some GPCRs act via
PKA- and PKC-dependent signaling to regulate NMDARs and
thus metaplasticity at CA1 synapses. Finally, we will discuss
how downstream signaling from a RTK (itself regulated by a
GPCR) regulates NMDAR activity indirectly by targeting
proteins that regulate polymerization of the actin cytoskeleton.4. GPCRs and PKA Regulation of NMDARs
In striatal neurons D1 dopamine receptors (Gαs-coupled)
enhance adenylate cyclase, increase cAMP, and activate PKA
which then phosphorylates and activates the protein phospha-
tase inhibitor, DARPP-32. Phosphorylated DARPP-32 is a
potent inhibitor of the serine/threonine protein phosphatase 1
(PP1) [35]. In hippocampal neurons PP1 is inhibited by a
different protein, Inhibitor 1, which is also a substrate of PKA
[36,37]. Therefore PKA activation leads to inhibition of PP1
and decreased dephosphorylation (i.e. enhanced phosphoryla-
tion) of downstream substrates including NMDARs [38]. In
CA1 neurons PKA phosphorylated inhibitor 1 likely interacts
and inhibits PP1 causing an enhanced phosphorylation of
NMDARs [36,37]. NMDAR activity in hippocampal neurons is
down regulated by PP1/PP2A and is enhanced by PP1
inhibition [39]. Others have shown that PKA and NMDARs
are closely linked via an A kinase anchoring protein (AKAP)
[40]. In this model, constitutively active PP1 keeps NMDA
channels in a dephosphorylated and low activity state. Both
PKA and PP1 are bound to the AKAP scaffolding protein,
yotiao. Upon activation PKA phosphorylates PP1 and decreases
its activity, leading to a shift in the balance of the channel to a
higher phosphorylation state and a higher activity state [33,41].
The scaffolding and localization of PKA and PP1 to the
NMDAR enhances the efficiency and specificity of this
signaling pathway [41]. Others have reported that β-adrenergic
receptors acting via PKA regulate the desensitization of
NMDAR mediated synaptic currents (epscNMDA) [42], possibly
through a direct phosphorylation of NMDAR subunits.
A recent and elegant study by Skeberdis et al. [43] has
demonstrated that the Ca2+ permeability of NMDARs is
enhanced by PKA without any alteration in the amplitude of
the epscsNMDA. Blockers of PKA inhibited the induction phase
of LTP at CA1 synapses presumably by decreasing the
NMDAR-induced entry of Ca2+ and supporting a role for
PKA as a “switch” (metaplasticity) mechanism of LTP control
[37,44,45].
5. GPCR regulation of NMDARs via PKC and tyrosine
kinases
We and others have established that a number of GPCRs
(those that couple to Gαq) upregulate NMDAR-mediated
currents and/or epscsNMDA recorded in hippocampal neurons
in culture or in situ in the hippocampal slice. These include
muscarinic, LPA, and mGluR5 receptors [46–55]. They do so
via a sequential signal pathway composed of PLC, PKC, Ca2+,
IP3R, CAKβ or Pyk2 (cell adhesion kinase β also called proline
rich tyrosine kinase 2) and Src (Fig. 1). Therefore, several Gαq-
coupled receptors act upon NMDARs by enhancing tyrosine
kinase activity. The importance of this signaling cascade is
highlighted by the finding that LTP at CA1 synapses requires
activation of Pyk2 and Src [48]. One means by which Gαq-
coupled receptors may increase NMDAR signaling is by
increasing their surface expression. Indeed, in a Xenopus
expression system and in cultured hippocampal neurons
Fig. 1. A sequential Gαq signal cascade leads to a Src-dependent enhancement
of NMDAR activity in CA1 pyramidal neurons. GPCR activation (e.g. M1,
mGluR5, LPA) leads to the stimulation of phospholipase β1 (PLCβ1) and the
production of inositol triphosphate (IP3) leading the release of intracellular
calcium. The conjoint production of diacylglycerol results in stimulation of
protein kinase C (PKC). The increased calcium and PKC lead to the stimulation
of the non-receptor tyrosine kinase, Pyk2; which then provides an SH2 docking
site for Src. This interaction results in the enhancement of NMDAR activity. Src
is anchored in the vicinity of the NMDAR via the binding of its unique domain
to the scaffolding protein ND2.
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the insertion of new NMDARs in the plasma membrane and this
requires activation of non-receptor tyrosine kinases [51].
Similarly the trafficking of NMDARs to the surface of cultured
striatal neurons by D1 dopamine receptors is dependent upon
tyrosine kinase activity [56].
6. PACAP receptors in CA1 neurons
Pituitary adenylate cyclase activating peptide (PACAP)
occurs as a 38-amino-acid or a truncated 27-amino-acid peptide
[57]. Acting through PAC1 receptors highly expressed in the
hippocampus [58–61], PACAP has been reported to potentiate
NMDAR responses in CA1 neurons [62,63]. The regulation of
NMDARs by PACAP signaling through PAC1Rs may underlie
its reported ability to regulate hippocampal LTP as well as
memory retention and consolidation [64–68]. PAC1R signals
either through Gq/11 to phospholipase C (PLC) [69,70] or
alternatively to an adenylyl cyclase pathway via a Gαs [70,71].
Therefore, PACAP stimulates both PKA- and PKC-dependent
signaling pathways [72] and raises the question of how
NMDAR are regulated by PACAP receptors in CA1 hippo-
campal neurons (Fig. 2).
Our approach to answer this question was to examine the
impact of cell signaling pathways on NMDARs in cultured,
acutely isolated and slice CA1 hippocampal neurons usingcombined electrophysiological recordings and biochemical
measurements. Parallel studies were done both on actual
synaptic currents as well as currents evoked by exogenous
applications of NMDA [73]. In cultured cells we used
pharmacologically or kinetically isolated miniature epscsNMDA
and in conventional slices we recorded evoked epscsNMDA
using Schaffer Collateral stimulation. Each preparation has its
advantages and disadvantages but isolated CA1 pyramidal
neurons provide a method for studying rapid agonist applica-
tions with excellent accessibility of reagents. Rapid applications
of NMDA (3 ms solution exchange time constant) evoke
currents characterized by a rapid rise to a peak (Ipeak) followed
by desensitization to a quasi-steady state (see Fig. 4 for
example). In actual experiments each neuron served as its own
control. For example, we initially recorded stable Ipeak before
applying a GPCR agonist such as PACAP38. The agonist is
applied for a short period of time and then it is rapidly washed
away. Peak NMDAR currents are then monitored for periods of
tens of minutes and observed changes are recorded long after
exposure to the GPCR agonist. Responses of individual neurons
are then averaged giving highly reliable measures of the degree
of modulation. Isolated cells lose much of their dendritic
processes during isolation. Nevertheless, peak NMDAR
currents (Ipeak) from isolated cells and epscsNMDA are
modulated in parallel by D4 dopamine [31], PDGFRs [74,75],
muscarinic [49], mGluR5 [46] and PAC1 (see below) receptors
suggesting that synaptic receptors are still present in isolated
cells. Similarly, PKC, Pyk2, and Src enhance both peak currents
and epscsNMDA [48,49,76,77]. Indeed we suspect that Ipeak is
mediated in large part by receptors that only contain NR2A
subunits (NR2AA, see below) (but not exclusively) whilst
receptors containing only NR2B subunits (NR2BB) contribute
more to the steady-state currents. This is based upon the much
higher probability of opening of NR2AA versus NR2BB
receptors [78,79] as well as by the sensitivity of Ipeak to very low
concentrations of the NR2AA selective antagonist, NVP-
AAM077 [80].
7. PACAP signals via PKC, Pyk2 and Src to NMDARs
Low concentrations (1 nM) of PACAP38 enhance pharma-
cologically isolated epscsNMDA at CA1 synapses (Fig. 3) and
this effect is eliminated by the inclusion of the Src-specific
antagonist Src(40–58) in the recording patch pipettes [73].
This is paralleled by an enhancement of Ipeak in acutely
isolated CA1 pyramidal neurons (taken from P14 to P20 rats)
(Fig. 4). The effect of PACAP38 is seen at extremely low
concentrations (10 pM to 1 nM, isolated cells) and it is
suppressed by a selective antagonist of the PAC1R. This
response requires G-proteins as GTP-γ-S occludes and GDP-
β-S blocks the enhancement induced by PACAP38 [73]. This
might seem a self-evident result but there are reports of GPCR
signaling via mGluRs in hippocampal neurons independent of
G-proteins [81].
The G-protein subtype involved in this signaling pathway is
Gαq as application of a specific RGS2 protein [82], which
selectively prevents the binding of Gαq to GPCRs, eliminated
Fig. 3. PACAP38 enhances NMDA currents in hippocampal slice. (A)
Application of 1 nM PACAP38 to hippocampal slices caused increased
amplitude in NMDA currents. Pyramidal cells were recorded in a whole cell
configuration. NMDA peak currents reached a maximal increase approximately
8 min following application. Normalized peak amplitude for PACAP treated
cells was 167±10% compared to baseline (n=6). When Src (40–58) (25 μg/mL)
was included in the patch pipette PACAP38 failed to elicit a response;
normalized peak current 102±2% (n=6), p<0.005, unpaired t-test, data
obtained at 20 min of recording. The black bar indicates time and duration of
1 nM PACAP38 application. (B) Sample traces from individual cells with and
without Src(40–58) in the patch pipette at baseline (t=0 min) and following
PACAP38 application (t=20 min). (From Macdonald et al. [66]).
Fig. 2. An alternative Gαs signal cascade leads to a Fyn-dependent enhancement
of NMDAR activity in CA1 pyramidal neurons. GPCR activation (e.g. PAC1R)
leads to the stimulation of adenylyl cyclase (AC), the production of cyclic
adenosine monophosphate (cAMP) and the stimulation of protein kinase A
(PKA). PKA leads to the dissociation of Fyn kinase from the receptor for
activated C kinase 1 (RACK1) relieving the inhibition of Fyn and permitting it
to increase the tyrosine phosphorylation of the NR2B subunit of the NMDAR
and causing an enhancement in receptor activity. (Based on Yaka et al. [119]).
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possibility is that PACAP38 binding induces a dynamic
switching between Gαs and Gαq as described for β2-adrenergic
receptor [83]. However, the enhancement of NMDARs is
substantially attenuated in mice lacking PLCβ1 whilst the
PACAP38-induced increase in cAMP levels in the hippocam-
pus is unaltered arguing against such a switch [73]. Inhibition of
PKC, Pyk2, or Src each prevented the PACAP-38 induced
potentiation of NMDAR peak currents confirming that the
PAC1R is linked via a Gαq/PLCβ1/PKC/Pyk2/Src signal
cascade.
The Ron group has proposed that the Src-family kinase, Fyn,
and NR2B form a complex with RACK1 whereby the activity
of Fyn is inhibited [62,63,84]. RACK1 is one member of a
family of scaffolding proteins which interact only with activated
PKC, in a potentially isoform-specific manner (e.g. βIIPKC to
RACK1) [85,86]. RACK1 has sequence homology with the β
subunit of G proteins and both are members of a family of
regulatory proteins made up of highly conserved repeating units
usually ending with Trp-Asp (WD). RACK1, with seven WD
units, forms a “propeller-like” structure. Activated Src also
binds via SH2 sites to phosphotyrosyl groups in the 6th
propeller (WD) domain of RACK1 [87] and it is inhibited as a
result of this interaction [85,87,88]. They have proposed that
PACAP38 induced stimulation of PKA leads to a dissociation of
Fyn and NR2B from the first WD propeller region of RACK1,
freeing Fyn to phosphorylate NR2B receptors (Fig. 2). They
also provided evidence that Fyn and the NR2B subunit may
interact with the same binding region of RACK1. Recently, they
have shown that PACAP38 enhances field epspsNMDA in the
CA1 region of hippocampal slices. This likely involved NR2BB
containing NMDARs as the effect of PACAP was sensitive to
ifenprodil. Furthermore, in slices from fyn−/− knockout micethey reported that PACAP38 failed to potentiate field epsps-
NMDA [62]. They proposed that the activation of PKA by
PACAP allows Fyn-dependent phosphorylation of NR2B
receptors. Critical to this interpretation is the use of peptides
designed to interfere with the binding of NR2B receptors and
Fyn to RACK1. Salter points out a flaw in that one of the
peptides targeted a region of Fyn that is shared with most other
Src family kinases, including Src itself [24]. Therefore the
peptide employed would modulate Src as well as Fyn's
interactions with RACK1.
Our results with the effects of PACAP38 on Ipeak [73]
conflict substantially with those of Yaka et al. [62,63,89]. The
most critical point is our evidence that the Src selective inhibitor
peptide Src(40–58) [24,26], which mimics the unique region of
Src and not those of any of the other family tyrosine kinases,
completely blocks the PACAP38 induced potentiation of Ipeak
as well as the pharmacologically isolated epscsNMDA in CA1
neurons in situ. Most importantly Src binds by its unique
domain to an identified region of ND2 (residues 239–221), a
protein which serves as the major scaffolding protein for Src at
Fig. 5. A potential for cross talk between the Gαs and Gαq signal cascades
regulating NMDAR activity in CA1 pyramidal neurons. In this scenario Gαq
coupled receptors enhance Src-dependent NMDAR activity as previously
described. However, stimulation of PKA activation via Gαs and cyclic AMP
signaling targets the C-terminal Src kinase (Csk) by phosphorylating serine 364.
Csk then phosphorylates tyrosine 527 of Src strongly inhibiting Src activity and
down regulating its ability to enhance NMDAR activity.
Fig. 4. PACAP38 enhances peak currents in isolated CA1 pyramidal neurons.
(A) Application of PACAP38 (1 nM) to acutely isolated CA1 pyramidal neurons
resulted in an increase of NMDA-evoked peak currents that outlasted the period
of application, did not reverse during washout and persisted throughout the
recording period. NMDA-evoked peak currents in control cells were unchanged
throughout the time course of the experiment. Cells treated with 1 nM PACAP38
had significantly larger NMDA-evoked peak currents (control: 98±7%, n=9;
1 nM PACAP38: 140±5%, n=9, p<0.001, unpaired t-test, data obtained at 20
min of recording). The black bar indicates time and duration of 1 nM PACAP38
application. (B) Sample traces of NMDA-evoked currents for control and
PACAP38 treated cells. Traces represent points immediately prior to PACAP38
application (t=5 min) and 10 min following PACAP38 application (t=20 min).
(From Macdonald et al. [66]).
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Indeed, Src(40–58) acts by displacing Src from ND2 and this
inhibitor does not alter the association of ND2 with NMDARs
nor does it alter the catalytic activity of Src [90]. In addition, we
observed that the PACAP38 induced potentiation of Ipeak is
blocked by NV-AAM077 but not by ifenprodil or Ro 25-6981
(unpublished), suggesting that PACAP38 is regulating NR2A-
containing receptors.
To address some of these discrepancies between our work
and that of the Ron group we designed and synthesized two
peptides which mimic either the Fyn binding site (peptide R1)
or alternatively the Src binding site (peptide R6) of RACK1.
We introduced these peptides into isolated CA1 neurons via the
patch pipettes. As would be anticipated from Yaka et al.
[62,63,89], R1 enhanced NMDAR currents on its own pre-
sumably by competing Fyn away from WD1. However, a
similar, if not more robust enhancement, was observed when
the R6 peptide was included in the patch pipette. Perhaps of
some importance was our observation that the kinetics of theenhancement by R6 was substantially faster than that for R1.
Unexpectedly, both the R6 and R1 induced enhancements of
NMDAR currents were blocked by the co-application of the Src
selective peptide, Src(40–58) suggesting that Src is the mediator
of both R1 and R6 induced potentiation. These results imply that
Fyn's modulation of NMDARs requires Src activation (thus Fyn
maybe upstream of Src at least within the RACK1 complex).
This conclusion conflicts with results from fyn−/− mice where
PACAP38 induced potentiation was reportedly absent [62], but
suggests that there is some kind of permissive relationship
between Fyn and Src at CA1 synapses. One plausible
explanation for our differing results is that we have primarily
examined the Src-dependent modulation of NR2AA receptors in
contrast to the Ron's groups focus on NR2BB containing
receptors (see below). Indeed, PKA selectively enhances
currents mediated by recombinant NR2BB but not NR2AA
receptors when expressed in HEK293 cells [43]. Although this
result is somewhat in contradiction to an earlier report
demonstrating PKA-induced potentiation of NR2AA receptors
[33]. These conflicting results are likely attributable to the
specific substrates targeted by PKA. In the case of altered
NR2AA Ca2+ permeability, a direct phosphorylation of the
receptor protein would appear to be the mechanism of action.
However, enhanced currents could result from PKA interactions
with yotiao and the AKAP complex [33].
Still greater complexity can occur with GPCR signaling as
kinase substrates may include a variety of signaling proteins
linked to the eventual alteration in NMDAR activity. For
example, in previous experiments we demonstrated that cPKA
does not alter NMDAR single channel activity in outside-out
patches (see also [91]) taken from cultured hippocampal
neurons unless the channel activity has been previously
upregulated by applications of the Src selective activator
phosphopeptide EPQ(pY)-EEIPIA [75,92]. In other words,
Src's effects on NMDARs are permissive to the inhibitory
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Src and PKAwith regards to the regulation of NMDAR activity
may depend upon the C-terminal Src kinase (Csk) [93,94]. Csk
phosphorylates the c-terminus of Src and inhibits Src activity.
We have extensive preliminary data that Csk regulates
NMDARs and LTP via this mechanism. In turn, Csk is
activated by phosphorylation by PKA [95,96] suggesting that
PKA could inhibit the Src induced potentiation of NMDAR
currents by stimulating Csk and inhibiting Src (Fig. 5). The
extent of activation of Gαs vs. Gαq signaling pathways,
especially by GPCRs such as the PAC1 receptor that can couple
to both G-proteins, may dictate the extent of Src potentiation of
NMDARs, and subsequently the extent of LTP potentiation.
8. Could GPCRs act via the actin cytoskeleton to regulate
NMDAR activity?
The amplitude of NMDAR mediated currents indirectly
depends upon the balance between globular and filamentous
actin (F-actin). Depolymerization is associated with a rundown
of NMDAR currents [97]. The dependence of NMDARs upon
the cytoskeleton arises because the receptors are tethered to F-
actin via α-actinin [98–105]. Therefore, alterations in actin
polymerization can potentially regulate epscsNMDA.
Enhanced protein phosphatase activity is specifically
associated with LTD of epscsNMDA. For example, Morishita et
al. [106] have shown that low frequency stimulation of CA1
hippocampal synapses induces LTD with a long-lasting
depression of both isolated epscsNMDA and epscsAMPA. The
LTD of epscAMPA was dependent upon activation of PP2B
(calcineurin). In contrast, LTD of epscNMDAwas not. Instead the
depression of NMDARs was blocked by serine–threonine
phosphatase inhibitors (okadaic acid and microcystin; block
protein phosphatases 1 and 2A, PP1/2A). Furthermore, the
induction of LTD of epscsNMDA was associated with a stimulusFig. 6. Blots show that a D2-class dopamine agonist, quinpirole, transiently induce
transactivate PDGFRs in CA1 hippocampus. In addition, down stream Elk and ERK1/induced depolymerization of the actin cytoskeleton. Micro-
tubules were apparently not involved in this response [106].
This provides the first evidence that Schaffer Collateral
stimulation can modulate actin polymerization and in turn the
magnitude of NMDARs. These results are relevant to our own
work showing that myosin light chain kinase (MLCK) also
regulates NMDAR in cultured hippocampal neurons via
enhanced phosphorylation and sustained polymerization of F-
actin [34]. Furthermore, as PP1 and PP2A are key regulators of
the actin cytoskeleton it is consistent with our earlier
observations that NMDR activity is regulated by PP1/PP2A
[39].
9. Some GPCRs indirectly regulate NMDARs via growth
factor transactivation
GPCRs can stimulate uncontrolled growth through an
indirect activation or “transactivation” of tyrosine kinase
growth factor receptors (e.g. PDGFR) [107]. Transactivation
occurs when the agonist-induced engagement of a GPCR
causes tyrosine autophosphorylation of the growth factor
receptor and downstream activation of diverse signaling
pathways even though no growth factor ligand is present
(Fig. 6). Work by us has shown that D4 dopamine receptors
transactivate PDGFRs in CA1 hippocampal neurons leading to
a long-lasting inhibition of NMDARs [31]. A similar
transactivation of PDGFRs and inhibition of NMDAR is
observed in prefrontal cortical neurons although it is mediated
in these cells by D2 or D3 dopamine receptors [108]. Our work
established transactivation as a unique physiological mechan-
ism of inter-communication between transmitter systems
[7,31,107,109] (Fig. 7).
As with transactivation, activation of PDGFRβ with
PDGFBB (ligand) causes a long lasting inhibition of peak
NMDAR currents (Ipeak) [74]. The inhibition by PDGFBB iss autophosphorylation of PDGFRβ proving that D2-class dopamine receptors
2 phosphorylation occurs as a result of transactivation. (FromKotecha et al. [50]).
Fig. 7. Schematic shows that transactivation of PDGFR inhibits NMDARs by a Src-dependent mechanism. Dopamine D2 class receptors transactivate PDGFR in CA1
hippocampal neurons in the absence of any ligand for the PDGFR. The mechanism of the transactivation is poorly understood. Autophosphorylated PDGFR then leads
to the inhibition of NMDARs by a Src-dependent mechanism. Evidence suggests that phosphorylation of Y1021 and stimulation PLCγ [74,108] as well as a non-
receptor tyrosine kinase, Abelson's kinase (Abl) (unpublished) is required for this signaling pathway. We speculate that PKA phosphorylation of Csk could be an
intermediate component of the pathway.
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applications of the selective Src inhibitor peptide Src(40–58)
[75]. This peptide mimics the unique domain of Src and
interferes with its binding to the mitochondrial subunit protein
ND2 [90]. The depression was also blocked by inhibitors of the
serine–threonine phosphatases, PP1 and PP2A, but the
mechanisms by which PDGFRs inhibit NMDARs are poorly
understood. We reported that PDGFR-induced inhibition was
blocked by the actin stabilizing agent phalloidin suggesting that
PDGFR signaling is actin-dependent and may require an intact
cytoskeleton [74]. It remains unclear how the interplay between
PKA and Src, phosphatase activity, and regulation of the actin
cytoskeleton, lead to the long-lasting inhibition of peak
NMDAR currents in CA1 neurons.
10. Could subtypes of NMDARs be differentially regulated
by GPCRs?
NMDARs are tetrameric channels composed of dimers of
NR1 and NR2 subunits (NR1, NR1, NR2x, NR2x) [110] (and in
some cases NR3x). CA1 pyramidal neurons predominantly
express NR1a, NR2A and NR2B [111,112]. These receptors are
composed of either dimers of NR1 and NR2AA (NR1, NR1,
NR2A, NR2A) or NR2BB (NR1, NR1, NR2B, NR2B), but
triheteromeric channels NR2AB (NR1, NR1, NR2A, NR2B)
are also present [113]. Triheteromeric channels have pharma-
cological properties in between those of NR2AA and NR2BB
receptors. For example, recombinant NR2AA and trihetero-meric receptors are sensitive to a potent block by Zn2+(about
15 nM) whereas NR2BB and triheteromeric receptors are
selectively blocked by ifenprodil [114]. The N-terminal
domains of NR2A and NR2B subunits impart this differential
sensitivity to Zn2+ and ifenprodil [114].
In cultured hippocampal neurons NR2AA and NR2BB
receptors are preferentially sequestered in synaptic versus
extrasynaptic regions [115], respectively. This is supported by
evidence that extrasynaptic NR2BB receptors target a signal
cascade which modulates CREB transcription [116] whilst
synaptic NR2AA receptors do not [117–119]. Indeed, NR2BB
receptors are activated in excitotoxicity and lead to ischemic
cell death whilst NR2AA receptors may be neuroprotective
[117–122]. These results are consistent with demonstrations
that activation of extrasynaptic receptors induces “chemically-
induced” LTD (the LTD which occurs following bath applica-
tions of NMDA) whereas activation of synaptic receptors
induces LTP [123,124]. It should be recognized that synapti-
cally-induced LTD is not necessarily mediated by the same
mechanisms as “chemically-induced” LTD [123]. In spite of this
evidence, there is dynamic exchange of NMDARs between
extrasynaptic and synaptic regions [125] and NR2BB and
NR2AA receptors are likely both found in synapses. We have
preliminary evidence that NR2AA receptors are selectively
regulated by PAC1Rs. This is an important finding as different
signaling mechanisms may regulate NR2AA versus NR2BB
receptors and therefore GPCRs may be able to regulate different
compartments of NMDARs as well as different downstream
949J.F. MacDonald et al. / Biochimica et Biophysica Acta 1768 (2007) 941–951events following NMDR activation. The induction of synaptic
plasticity at CA1 synapses has also been reported to be
dependent upon NR2AA versus NR2BB receptors. In some
cases LTP could be dependent upon activation of NR2AA and
LTD upon NR2BB containing receptors [126]. However, these
results are controversial with evidence both for and against this
hypothesis. It remains to be determined whether or not GPCRs
target specific subtypes of NMDARs and thereby potentially
serve to differentially regulate the thresholds for induction of
LTP and LTD.References
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